+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Roadside Drug Testing Devices Market, Forecast to 2029

  • PDF Icon


  • 132 Pages
  • January 2022
  • Region: Global
  • Infinity Business Insights
  • ID: 5582324
The Roadside Drug Testing Devices market was valued at 674.2 million US$ in 2021 and is projected to reach 908.6 million US$ by 2029, at a CAGR of 3.8% during the forecast period.

This report focuses on the Roadside Drug Testing Devices market revenue at the global, regional, and company levels. From a global perspective, this report represents the overall Roadside Drug Testing Devices market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Asia Pacific, South America, and the Middle East and Africa. The report covers the:
- Market Revenue of the Roadside Drug Testing Devices Market from 2017 to 2029.
- Market Forecast for the Roadside Drug Testing Devices Market from 2021 to 2029.
- Regional Market Share and revenue from 2017 to 2029.
- Country Market share within the region from 2017 to 2029.
- Key Modality and Substance revenue and forecast.
- Company Market Share Analysis, competitive scenario, ranking, and detailed company profiles.
- Marker driver, restraints, and detailed COVID-19 impact on Roadside Drug Testing Devices Market.

The major players in the global Roadside Drug Testing Market are Dragerwerk AG & Co. KgaA, AK GlobalTech Corporation, MAVAND Solutions GmbH, and Cannabix Technologies Inc.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Thermo Fisher Scientific Inc
  • Becton, Dickinson and Company
  • Merck KGaA
  • STEMCELL Technologies Inc
  • Bio-Rad Laboratories, Inc
  • Beckman Coulter, Inc
  • Agilent Technologies, Inc
  • Drägerwerk
  • Cannabix
  • Securetec
  • Mavand